Evidence map›Paper›PMID 42291479›Full record

ReviewMedical cannabis and cannabinoids

The Persistence of Stigma and Other Challenges Experienced by Medical Cannabis Users: A Thematic Synthesis of Qualitative Studies.

Martina Breuning, Jason Nie, Mark Schlesinger, Lorraine Smith, Maya Lavie-Ajayi, Stephanie Babinski, Susan Law

Abstract readReview
In one paragraph

Review in Medical cannabis and cannabinoids. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martina BreuningDepartment of Self-Help Research, Medical Centre - University of Freiburg, Freiburg im Breisgau, Germany.
Jason NieInstitute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.
Mark SchlesingerDepartment of Health Policy and Management, Yale School of Public Health, Yale University, New Haven, CT, USA.
Lorraine SmithSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Maya Lavie-AjayiGender Studies Program, Ben Gurion University of the Negev, Beersheba, Israel.
Stephanie BabinskiDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Susan LawInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The legislation, practices, and guidance shaping patient and professional access to medical cannabis (MC) for managing chronic pain and other conditions vary widely across jurisdictions. Despite promising evidence of effectiveness, challenges persist for those trying to access or prescribe MC. Little is known about how patients navigate these complex environments. We aimed to understand the evidence related to personal lived experiences associated with using MC for chronic pain and other conditions in negotiating these challenges. Summary: We used a framework by Thomas and Harden for conducting a thematic synthesis of data gathered in a scoping review. Studies were included that used qualitative methods to capture lived experiences associated with using MC for chronic pain and other conditions. Our analysis identified themes relevant to patients and those caring for them. Forty-five studies met our criteria. Four interconnected themes were identified: (1) limited education and knowledge about medically appropriate use; (2) perceived stigma for patients and professionals; (3) persisting social consequences of stigma; and, (4) challenging pathways for patients seeking MC access. Key Messages: There has been remarkably little change in the association of stigma and MC in the literature over time and across jurisdictions and regulatory regimes. Future research comparing stigma experiences over time is needed to determine if these harms persist. Changing regulations to moderate stigma would foster patient-centered care.

Indexed as

Access to careChronic painMedical cannabisPatient experienceQualitative researchStigmaThematic synthesis

Identifiers

PMID42291479
PMCPMC13263005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.